bioMérieux Corporate | Press Releases

2010 First-Half Review

Mon, 6 Sep 2010 00:00:00 +0200

Continued Profitability Growth
- Operating income before non-recurring items up 10.8%
- Net income up 13.7%
Two acquisitions in China and five new partnership agreements
A solid R&D pipeline
An ambitious industrial plan

Hyglos Honored with 2010 Food Safety Innovation Award for Technology Used in bioMérieux’s VIDAS^® UP E. coli O157 (including H7)

Thu, 29 Jul 2010 00:00:00 +0200

bioMérieux, a world leader in the field of in vitro diagnostics, and Hyglos GmbH, the leader in applied phage protein technology, today announced that a team of scientists who developed a new diagnostic tool for food microbiologists is the recipient of the 2010 Food Safety Innovation Award given by the International Association of Food Protection (IAFP). Visit www.biomerieux-usa.com or www.biomerieux-usa.com/iafp2010

bioMérieux - First-Half 2010 Business Review

Thu, 22 Jul 2010 00:00:00 +0200

Sales: €651 million

Up 6% at constant exchange rates and scope of consolidation
Strong performance of clinical and industrial microbiology as well as VIDAS^®
Robust growth in emerging countries
2010 operating margin objective confirmed

Lab Informatics Expert Joins bioMérieux

Mon, 19 Jul 2010 00:00:00 +0200

A world leader in in vitro diagnostics, bioMérieux today announced the appointment of Jacques L. Baudin as Vice President, Commercial Operations Information Technology.

Data from Clinical Studies of bioTheranostics’ CancerTYPE ID^® and Breast Cancer Index^® Molecular Oncology Tests Presented at ASCO 2010 Annual Meeting*

Sun, 6 Jun 2010 00:00:00 +0200

bioTheranostics, a bioMérieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company’s CancerTYPE ID^® and Breast Cancer Index^® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.

bioMérieux Showcases Myla™ at ASM 2010: New Informatics Solution to Transform the Microbiology Laboratory

Tue, 25 May 2010 00:00:00 +0200

Innovative solution optimizes laboratory workflow and clinical information management. A world leader in in vitro diagnostics, bioMérieux presented Myla™, a revolutionary new middleware solution to improve connectivity, laboratory workflow and information management, at the 110th General Meeting of the American Society for Microbiology (ASM) in San Diego. Part of bioMérieux’s FMLA™* solutions and services, Myla is an intelligent browser-based application that consolidates and manages microbiology data generated from a variety of sources and converts these data into actionable information for treatment decisions. Designed to transform the way that laboratory managers and technicians work, Myla recaptures time spent on information retrieval and reporting activities through a simple dashboard-based user interface that provides full control of lab workflow.

Shimadzu and bioMérieux Enter into Partnership for Mass Spectrometry Applications in Microbiology

Fri, 21 May 2010 00:00:00 +0200

Shimadzu and bioMérieux announce today that they have entered into a partnership to commercialize a mass spectrometry system for bacterial identification in microbiology laboratories. bioMérieux will work with Shimadzu and their subsidiary, Kratos Analytical, to adapt their linear MALDI-TOF* mass spectrometry technology for optimized integration into the microbiology laboratory workflow. This new solution is planned for commercialization by bioMérieux in 2010, together with the microbial database acquired from AnagnosTec.

bioMérieux Strengthens North American Executive Management Team

Mon, 17 May 2010 00:00:00 +0200

Manuel Mendez to serve as Executive Vice President, Commercial Operations for bioMérieux Inc. A world leader in in vitro diagnostics, bioMérieux today announced the appointment of Manuel O. Mendez as Executive Vice President, North American Commercial Operations of bioMérieux, Inc. His new position becomes effective May 17, 2010.

bioMérieux Co-sponsors French Medical Days in Shanghai

Mon, 17 May 2010 00:00:00 +0200

bioMérieux plays a driving role in Sino-French healthcare cooperation:

• Organization of seminar on emergency medicine
• Inauguration of Sino-French Emergency Satellite Lab at Xinhua Hospital
• Renewal and extension of the partnership with Fudan University Shanghai Cancer Hospital
• Pilot project with the Shanghai Health Bureau on decentralized diagnostics in Community and County Healthcare Centers (CHC)

bioMérieux, a leader in the field of in vitro diagnostics, present in China for 22 years, is working closely with Chinese healthcare professionals and institutions to address major public health issues through a number of initiatives and partnerships.

bioMérieux and GlaxoSmithKline Enter into Alliance to Develop Molecular Theranostic Test for Cancer Treatment Selection

Mon, 10 May 2010 00:00:00 +0200

bioMérieux and GlaxoSmithKline (GSK) have signed an agreement to develop a novel molecular test for cancer. In this new collaboration, the two companies will develop a theranostic test to aid oncologists in choosing the appropriate treatment for metastatic melanoma (skin cancer).

bioMérieux - First Quarter 2010 Business Review

Wed, 21 Apr 2010 00:00:00 +0200

Sales up 6.4% at constant exchange rates and scope of consolidation.

bioMérieux and Knome Sign Strategic Partnership

Wed, 21 Apr 2010 00:00:00 +0200

Exclusive agreement to bring state-of-the-art genome sequencing technology to the in vitro diagnostics market. bioMérieux takes equity stake in Knome.

bioMérieux Acquires from AnagnosTec - Database and Expertise for Rapid Microbial Identification Using Mass Spectrometry

Mon, 12 Apr 2010 00:00:00 +0200

bioMérieux announces today that it has agreed on the terms for the acquisition of certain assets from AnagnosTec, a company based in the greater Berlin area, specialized in microbial identification with MALDI-TOF* mass spectrometry technology.

bioMérieux Introduces Myla™ at ECCMID: New Informatics Solution to Transform the Microbiology Laboratory

Mon, 12 Apr 2010 00:00:00 +0200

Innovative software:

consolidates and transforms microbiology laboratory data into actionable information for treatment decisions
recaptures time for lab managers through efficiency gains and full control of lab workflow

A world leader in in vitro diagnostics, bioMérieux presented Myla™, a paradigm-shifting software application, at the European Congress of Clinical Microbiology and Infectious Diseases in Vienna, Austria. Myla is a browser-based application that provides microbiology laboratory managers and technicians with a set of tools to revolutionize the way they work. It was designed by microbiologists for microbiologists to recapture the time spent on information retrieving and reporting activities through improved connectivity, laboratory workflow and information management. For more information, visit www.mylahelps.com.

bioMérieux’s PREVI™ Isola Wins the 2010 - Medical Design Excellence Award

Thu, 8 Apr 2010 00:00:00 +0200

The award highlights the automated media streaker’s breakthrough technology.
A world leader in in vitro diagnostics, bioMérieux announced today that its automated media streaker, PREVI™ Isola has received a 2010 Medical Design Excellence Award for contributions and advances in the design of medical products. This exclusive award recognizes products for their design and engineering features, including user-related functions that improve healthcare delivery and change traditional medical attitudes or practices. PREVI Isola was designed to revolutionize front-end media processing tasks, and it is a critical component in bioMérieux’s complete range of solutions and services for Full Microbiology Lab Automation (FMLA™): www.biomerieux-diagnostics.com/fmla

bioMérieux Corporate | Press Releases

2010 First-Half Review

Hyglos Honored with 2010 Food Safety Innovation Award for Technology Used in bioMérieux’s VIDAS® UP E. coli O157 (including H7)

bioMérieux - First-Half 2010 Business Review

Lab Informatics Expert Joins bioMérieux

Data from Clinical Studies of bioTheranostics’ CancerTYPE ID® and Breast Cancer Index® Molecular Oncology Tests Presented at ASCO 2010 Annual Meeting*

bioMérieux Showcases Myla™ at ASM 2010: New Informatics Solution to Transform the Microbiology Laboratory

Shimadzu and bioMérieux Enter into Partnership for Mass Spectrometry Applications in Microbiology

bioMérieux Strengthens North American Executive Management Team

bioMérieux Co-sponsors French Medical Days in Shanghai

bioMérieux and GlaxoSmithKline Enter into Alliance to Develop Molecular Theranostic Test for Cancer Treatment Selection

bioMérieux - First Quarter 2010 Business Review

bioMérieux and Knome Sign Strategic Partnership

bioMérieux Acquires from AnagnosTec - Database and Expertise for Rapid Microbial Identification Using Mass Spectrometry

bioMérieux Introduces Myla™ at ECCMID: New Informatics Solution to Transform the Microbiology Laboratory

bioMérieux’s PREVI™ Isola Wins the 2010 - Medical Design Excellence Award

Hyglos Honored with 2010 Food Safety Innovation Award for Technology Used in bioMérieux’s VIDAS^® UP E. coli O157 (including H7)

Data from Clinical Studies of bioTheranostics’ CancerTYPE ID^® and Breast Cancer Index^® Molecular Oncology Tests Presented at ASCO 2010 Annual Meeting*